◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Jacobson Pharma Corporation Limited (2633) Financial History

Name: Jacobson Pharma Corporation Limited (2633) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Jacobson Pharma Corporation Limited (2633) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kwun Tong, Hong Kong with about 1,768 employees. Its market capitalization is roughly HKD 2 billion. In the fiscal year ended 2026-03-31, 2633 reported HKD 1.6B in revenue and HKD 302M in net income.

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally.

Interactive charts & full statements →

2633 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	HKD 1.6B	HKD 1.6B	HKD 1.5B	HKD 1.3B	—
Gross Profit	HKD 678M	HKD 693M	HKD 620M	HKD 539M	—
Operating Income (EBIT)	HKD 358M	HKD 369M	HKD 288M	HKD 270M	—
Net Income	HKD 302M	HKD 301M	HKD 267M	HKD 251M	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2633 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(HKD 315M)	(HKD 60M)	(HKD 94M)	(HKD 104M)	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2633 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	HKD 3.6B	HKD 3.6B	HKD 3.5B	HKD 5.4B	—
Total Liabilities	HKD 1.2B	HKD 1.2B	HKD 1.1B	HKD 2.1B	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2633 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

6896 · Golden Throat Holdings Group Company Limited — $2 billion
PBH · Prestige Consumer Healthcare Inc. — $2 billion
2561 · VISEN Pharmaceuticals — $2 billion
BHC · Bausch Health Companies Inc. — $2 billion
DMP · Dermapharm Holding SE — $2 billion
PRGO · Perrigo Company plc — $2 billion
ANIP · ANI Pharmaceuticals, Inc. — $2 billion
TRLV · Trulieve Cannabis Corp. — $2 billion

← 2632 All “0-9” companies 2635 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.